Skip to main content

Peripheral Nerve Stimulators Market by Application, Types, and Techniques, Rise value of USD 3 billion to 2020

Peripheral nerve stimulator is a system generally used for the treatment of neurological diseases and disorders with symptoms such as complex regional pain syndrome, neck pain, low back pain, and painful nerve injuries. The prevalence of these diseases and disorders is increasing, which is augmenting its demand and is expected boost growth of the peripheral nerve stimulators market. As per the National Institute of Neurological Disorders and Stroke, around 600 neurologic disorders affect approximately 50 million U.S. citizens every year.
The large prevalence of neurological disorders especially among the elderly population coupled with increase in healthcare expenditure for exploring effective treatments for neurological disorders are the major drivers for growth of the peripheral nerve stimulators market. However, low screening rate or late screening mainly in the developing countries is restraining growth of the market. Also, this scenario is likely to be same for next some years, which will offer growth possibilities and chances to expand the awareness programs globally.
Additionally, the neuropathic pain is one of the common health problems across industrialized countries and affects around 40%-60% of the geriatric population globally. This enormous presence of the untreated patients are creating need for the advanced and effective treatment set, which is driving growth of the global peripheral nerve stimulators market.
Competitive Analysis:
Some of the major companies in the global peripheral nerve stimulators market include Braun Melsungen AG, Enteromedics, Avanos Pain Management, ElectroCore, Inc., NeuroMetrix, Inc., NeuroSigma, Inc, SPR Therapeutics LLC, SUNMED INC., Stimwave LLC., Vygon SA, Medline Industries, Inc., and Boston Scientific Corporation.
Segmentation:
The peripheral nerve stimulators market is segmented on product, end user, and region.
On the basis of end user, the market report is segmented into hospitals & clinics, ambulatory centers, and specialty center.
On the basis of product, the market report is segmented into transcutaneous and implantable.
Regional Analysis:
Regionally, the peripheral nerve stimulators market is segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa. Of these, the Americas is estimated to remain dominant in the global peripheral nerve stimulators market in the coming period owing to the large patient pool suffering from neurological disorders coupled with strong presence of key players in the market. Additionally, the advent of advanced technologies for treatment of these neurological disorders owing to awareness about disorders and highest prevalence of screening are fuelling growth of the global peripheral nerve stimulators market.
However, the market in Asia Pacific is estimated to be largely expanding region owing to high investment for improving healthcare infrastructure coupled with demand for robust treatments for treating these disorders. Additionally, increasing screening of the neurological disorders which increases demand for its effective and efficient treatments in the region. This scenario is likely to be same in coming year, which in turn will fuel growth of the market in coming years.
Browse Complete 100 Pages Premium Research Report along with Detailed TOC at: https://www.marketresearchfuture.com/reports/peripheral-nerve-stimulators-market-8056
Industry News:
In September 2019, Checkpoint Surgical received a breakthrough from the FDA and electro stimulation therapy for treating nerve injury. The system is aimed to improve outcomes after surgeries to bolster nerve regeneration.
About Market Research Future: Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Market Research Future
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Growth Drivers, Restraints and Opportunities, Forecast To 2025

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size Research Report: Information by Treatment (Drug Class (Mitogen-Activated Protein Kinases (MAPK) Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors, Others), Oxygen Therapy, Lung Transplant, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025 Global  Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size  Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. Some of the key players operating for the global market analysis are  Boehringer Ingelheim GMBH, Biogen, Novartis AG, Medicinova, Inc., Bristol-Myers Squibb Company, Galapagos NV, F. Hoffmann-La R...
3 comments
Read more

Peptic Ulcer Drugs Market Rapid Development By Manufactures Business Growth Future

  Peptic Ulcer Drugs Market Scenario: Peptic ulcer drugs are used to treat erosion of the gastrointestinal lining due to a variety of factors. Peptic ulcer is the result of an imbalance between aggressive and defensive fluids in the stomach. Peptic ulcer includes gastric, esophageal and duodenal ulcer. The global peptic ulcer drugs market was valued at approximately $29 billion in 2015, and is expected to reach $36.27 billion by 2022. Thus, the market is expected to show an average growth at a CAGR of 3.8 % from 2016 to 2022. The major driving factors for petic ulcers drug market are stress, drug induced ulcers, growing rate of infection by H.Pyrroli, changes in food, rise in cancer, tobacco and alcohol use. Constraining factors of this market are patent expiry, comparatively good treatment regimen of proton pump inhibitors, resistance of H.Pyrolli, extreme market fragmentation into many companies and great penetration of generics. Avail a Free Sample@  https://www.market...
Post a Comment
Read more

Middle East And Africa Pediatric Healthcare Market Development Research with Forthcoming Opportunities and Challenges

  Middle East And Africa Pediatric Healthcare Market Share, Application And Growth Analysis, By Type Of Diseases (Short Term Diseases, Chronic Diseases And Others), By Therapeutics (Cardiology, Allergy And Immunology, Gastroenterology, Infectious Disease And Others), By Treatment (Medication, Surgery, And Others) - Forecast To 2023 Paediatric Healthcare-Overview Paediatrics is a branch of medicine which deals with diagnosis and treatment of diseases related to paediatric group. It can be classified into the four categories namely neonates (from birth till the first 28 days of life), infants (29 days to 2 years), children (2 years to 12 years) and adolescents (12 years to 18 years). Paediatrician is a medical professional who specializes in providing treating the paediatric group. Paediatric medical devices are devices used for the treatment and care of infants and children below 18 years having some healthcare issues. Avail a Free Sample@  https://www.marketresearchfuture.com/...
Post a Comment
Read more